CLOs on the Move

MedLite ID

www.medliteid.com

 
MedLite ID is an easy-to-use, disposable medical device that enables clinicans to accurately and efficiently identify a single medication infusion line against similar infusion lines in any light setting. The ninth leading cause of medical-error deaths in the United States involves infusion line confusion, and nearly 65 percent of those cases are related to the medication infusion line. MedLite ID eliminates infusion confusion by providing indicators with built-in wireless light technology at the medication bag, connector, and to patient. Each MedLite ID device is unique to its individual medication infusion line and cuts the process of infusion line identification to ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.medliteid.com
  • Atwood Innovation Plaza Suite 108 453 S 600 E.
    St. George, UT USA 84770
  • Phone: 435.652.7741

Executives

Name Title Contact Details

Similar Companies

Kreg Therapeutics

Kreg Therapeutics is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Clinical Technology Inc

Clinical Technology Inc is a Broadview Heights, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tearlab

TearLab Corporation develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by quantitatively testing for disease markers in tears at the point-of-care. Headquartered in San Diego, CA, TearLab Corporation`s common shares trade on the NASDAQ Capital Market under the symbol `TEAR` and on the Toronto Stock Exchange under the symbol `TLB`. Dry Eye Disease (DED) is a chronic, progressive disease. Morgan Stanley’s Dry Eye Market Report (2003) estimates that 30 to 60 million Americans suffer from dry eye symptoms. Only 10 million are diagnosed with the disease. Millions more suffer worldwide. The TearLab™ Osmolarity System provides the first quantitative and objective diagnostic technology that allows doctors to effectively manage their dry eye patients. TearLab will allow practitioners to diagnosis DED patients early in the disease process allowing for early intervention. TearLab received the CE Mark for its TearLab Osmolarity System in 2008 and FDA Clearance in 2009. TearLab is currently marketed globally in more than 14 countries including the US.

StemCyte

StemCyte, Inc is a Covina, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

southern cc ems

southern cc ems is a West Grove, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.